Mirtazapine to reduce methamphetamine use: a randomized controlled trial
about
Mirtazapine, and mirtazapine-like compounds as possible pharmacotherapy for substance abuse disorders: evidence from the bench and the bedsideOptimizing care for HIV-infected people who use drugs: evidence-based approaches to overcoming healthcare disparitiesPharmacotherapy of amphetamine-type stimulant dependence: an updateThe neurocircuitry of illicit psychostimulant addiction: acute and chronic effects in humansPharmacotherapeutic agents in the treatment of methamphetamine dependence.Pharmacological treatments for methamphetamine addiction: current status and future directions.Sustained-release methylphenidate in a randomized trial of treatment of methamphetamine use disorder.HIV prevention for people who use substances: evidence-based strategies.Methamphetamine: an update on epidemiology, pharmacology, clinical phenomenology, and treatment literatureEvent-level relationship between methamphetamine use significantly associated with non-adherence to pharmacologic trial medications in event-level analyses.Treatment of rats with an anti-(+)-methamphetamine monoclonal antibody shortens the duration of action of repeated (+)-methamphetamine challenges over a one month periodBarriers to HIV Care and Treatment Among Participants in a Public Health HIV Care Relinkage ProgramEffects of methamphetamine on the noradrenergic activity biomarker salivary alpha-amylase.Context-dependent effects of a single administration of mirtazapine on the expression of methamphetamine-induced conditioned place preference.Pervasive Heavy Alcohol Use and Correlates of Increasing Levels of Binge Drinking among Men Who Have Sex with Men, San Francisco, 2011Assessment of safety, cardiovascular and subjective effects after intravenous cocaine and lofexidine.Clinical implications of drug abuse epidemiologyAdapted personalized cognitive counseling for episodic substance-using men who have sex with men: a randomized controlled trialCreatine as a Novel Treatment for Depression in Females Using Methamphetamine: A Pilot StudyTesting for amphetamine-type stimulant (ATS) use to ascertain validity of self-reported ATS use among young female sex workers in Cambodia.Aripiprazole for the treatment of methamphetamine dependence: a randomized, double-blind, placebo-controlled trial.Aggregate versus day level association between methamphetamine use and HIV medication non-adherence among gay and bisexual men.Not just the needle: the state of HIV-prevention science among substance users and future directionsSpecific psychiatric correlates of acute care utilization among unstably housed HIV-positive adultsMethamphetamine psychosis: epidemiology and managementUsing Bayes factors for testing hypotheses about intervention effectiveness in addictions research.A review of therapeutic uses of mirtazapine in psychiatric and medical conditions.Comprehensive clinical care for men who have sex with men: an integrated approach.Using conditioned place preference to identify relapse prevention medications.Novel interventions to prevent HIV and HCV among persons who inject drugs.Extended-release naltrexone for methamphetamine dependence among men who have sex with men: a randomized placebo-controlled trial.Continued Transmission of HIV Among Young Adults Who Inject Drugs in San Francisco: Still Room for Improvement.The neurobiological mechanisms of physical exercise in methamphetamine addiction.Extended-release methylphenidate for treatment of amphetamine/methamphetamine dependence: a randomized, double-blind, placebo-controlled trial.Commentary on Konstenius et al. (2014): on medication development for stimulant addiction.No evidence of subgroups found in amphetamine consumers in Iran.Methamphetamin
P2860
Q24622161-474142D6-AA0F-49D9-8BFF-8A8DBCE65EE1Q26865313-C354EB70-6BE6-449B-9B78-9FDF6E5CE94DQ26991936-133B4BCE-07DA-44DD-9C41-775F9A2973A4Q28236333-2F7A9AE4-A578-495C-82CA-338E726D1408Q30235058-1B1DA4D7-EBD1-4D04-9E7B-A836872C27C9Q30240173-A8538127-C10C-402C-BE57-02BB9C161E4FQ34021980-29237A19-5E91-4336-87FC-3C7007C02C2DQ34154119-EF55BB7E-302D-4CD3-AB3A-18DC9920BA77Q34181746-9F7BD791-DD40-4683-9B45-C0A898DAEBE6Q34219147-9CD69456-E1A7-44B9-B419-B9C2940FEB3DQ34602548-4DF31E19-2709-4A64-A806-CCC025263EC2Q35540862-4E29C737-4008-481A-A83C-BC8125777C23Q35609720-9D110BB9-1B32-4006-BE20-6223751B944EQ35747260-65963992-7F36-48A7-8FE0-18E11FC7AA68Q35916028-5469596B-1C2E-4987-9514-C38FA3B965BAQ36036175-019D49DF-38C6-45C8-8F5E-A1BCCCAEA8C1Q36057853-8CD2506A-5B31-4F46-BC24-EDA9B41FA6BEQ36306978-23723F11-BC29-46FB-A163-40465DB21AC2Q36387048-8B7B442A-9066-4806-899C-4418B47A664EQ36427002-84A1B079-5080-4833-82F8-04EE20DFF829Q36698847-493D585C-6E18-4E73-891C-E970464F58B7Q36813501-18799B10-A0FA-46D4-9419-09A704902AC6Q37084003-21666E40-C59B-47B7-98AE-00786C5DC7E5Q37212457-D31FB66D-410A-46F4-BCB9-6B128CE59EAAQ37265315-2C38F7A6-1724-406C-B632-47A062106302Q37417696-9C3C90E0-3DC6-4465-B139-DC24D0695689Q37533880-4D71B4E5-4A1E-482D-8BBF-F79B06AA4582Q38028184-C58AF19B-A4A2-4ABA-8249-5AA7F6428650Q38107338-959FFCF7-1137-4569-94C4-3110408EC398Q38318678-0E5145CF-1E92-458A-99E9-7938EC1A9D68Q46165138-2381BDD7-3AEA-477D-9AC3-AA02DBC8E0D4Q46964805-C08B851F-7ED9-4360-83A4-7DB432012F8FQ47268750-C22F1F71-E30F-4E90-9DCD-537C831FF8EBQ52302064-F0B5576F-2632-4E8D-B8B9-DE6A120C01B4Q52304091-8B5D2784-72F3-4FCF-9FB2-F0C08582FB3CQ55408568-9A913748-C40D-452B-B619-13DBD615625DQ56639321-7125B584-A459-4F97-B58E-E406A743BB03
P2860
Mirtazapine to reduce methamphetamine use: a randomized controlled trial
description
2011 nî lūn-bûn
@nan
2011 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Mirtazapine to reduce methamphetamine use: a randomized controlled trial
@ast
Mirtazapine to reduce methamphetamine use: a randomized controlled trial
@en
Mirtazapine to reduce methamphetamine use: a randomized controlled trial
@nl
type
label
Mirtazapine to reduce methamphetamine use: a randomized controlled trial
@ast
Mirtazapine to reduce methamphetamine use: a randomized controlled trial
@en
Mirtazapine to reduce methamphetamine use: a randomized controlled trial
@nl
prefLabel
Mirtazapine to reduce methamphetamine use: a randomized controlled trial
@ast
Mirtazapine to reduce methamphetamine use: a randomized controlled trial
@en
Mirtazapine to reduce methamphetamine use: a randomized controlled trial
@nl
P2093
P2860
P3181
P1433
P1476
Mirtazapine to reduce methamphetamine use: a randomized controlled trial
@en
P2093
Deirdre McDermott Santos
Glenn-Milo Santos
Grant N Colfax
James Gasper
Moupali Das
Steve Shoptaw
Tim Matheson
P2860
P304
P3181
P356
10.1001/ARCHGENPSYCHIATRY.2011.124
P407
P577
2011-11-01T00:00:00Z